clinicalomicsprowebdirectory
News & Features
Topics
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
Magazine
Multimedia
Webinars
eBooks
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Search
Advertise
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Lead Generation Campaigns
Email Nurture Campaigns
Custom Content Solutions
About Us
Contact Us
Mary Ann Liebert Publishers
Create a Free Account
Log In
Clinical OMICs – Molecular Diagnostics in Personalized Medicine
News & Features
News & Features
New Guidelines Released for Genetic Testing Post-PCI
News & Features
IsoPlexis Wins $4M NCI SBIR Grant toward Commercializing IsoLight System
News & Features
Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery
Bioinformatics
Study of Multiethnic Groups Reveals 27 New Disease-Associated Variants
News & Features
New Targets Identified For Lupus and Rheumatoid Arthritis
Topics
All
Precision Medicine
Biomarkers
Molecular Dx
Informatics
New Products
News & Features
New Guidelines Released for Genetic Testing Post-PCI
News & Features
IsoPlexis Wins $4M NCI SBIR Grant toward Commercializing IsoLight System
Molecular Dx
Gut Microbiome Changes Can Help Diagnose Fibromyalgia
News & Features
Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery
Magazine
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 3
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 2
Magazine
Clinical OMICs Magazine Volume 6, Issue No. 1
Magazine
Clinical OMICs Magazine Volume 5, Issue No. 6
Magazine
Clinical OMICs Magazine Volume 5, Issue No. 5
Multimedia
All
Webinars
eBooks
Webinars
In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology
eBooks
Rethinking Rx-Dx Codevelopment
Webinars
Liquid Biopsy and ddPCR: A Match with Quality in Mind
Multimedia
Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine
Subscribe
Create a Free Account
Log In
Get Clinical OMICs Magazine
Get Clinical OMICs eNewsletters
Get the Clinical OMICs Mobile App
Get Clinical OMICs News from Alexa
Home
Precision Medicine
Technology
Technology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Technology
10 Leading Immuno-Oncology Startups
March 25, 2019
Technology
Mammoth Competition: Feng Zhang, Partners Launch CRISPR Dx Company
March 22, 2019
Technology
Viome, Helomics Partner on Personalized Ovarian Cancer Treatments
March 21, 2019
Technology
TGen Launches Software to ID Tumor-Causing Mutations from Archival Tumor Samples
March 21, 2019
Technology
Ambry and My Gene Counsel Team Up on Tests to Confirm...
March 19, 2019
Technology
Broad Institute, Pattern.org, LUNGevity Foundation Partner to Develop Lung Cancer Models
March 18, 2019
Technology
UK Commits £45M Toward Capacity Expansion at EMBL-EBI
March 15, 2019
Technology
Myriad Genetics Gets Medicare Coverage for myPath Melanoma Test
March 14, 2019
Technology
Lucence, Stanford Researcher to Develop AI Algorithms for Liver Cancer Treatment
March 14, 2019
Technology
BGI Genomics to Commercialize Natera’s Signatera Assay in China
March 13, 2019
Load more
Scroll Up
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1322-218x150.jpeg "Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-218x150.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
![Myriad Genetics has received a final local coverage determination for its myPath Melanoma test from the Medicare Administrative Contractor Palmetto GBA MolDx. [Myriad Genetics]](https://www.clinicalomics.com/wp-content/uploads/2019/03/2189-324x160.jpeg "Myriad Genetics Gets Medicare Coverage for myPath Melanoma Test")
![Lucence Diagnostics will partner with a Stanford University researcher to develop AI algorithms designed to improve the diagnosis and treatment of liver cancer. [Lucence Diagnostics]](https://www.clinicalomics.com/wp-content/uploads/2019/03/2187-324x160.jpeg "Lucence, Stanford Researcher to Develop AI Algorithms for Liver Cancer Treatment")
